- Selected SEP-204 as development candidate for Graves' Disease and Thyroid Eye Disease (TED)
- Favorable preclinical PK profile supporting once-daily oral dosing; Phase 1 trial planned for Q1 2027
Bullish AI Sentiment (+2.0 / 10)
Signal #129579 · SEC 8-K
$SEPN SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $SEPN filing catalyst
Why did $SEPN trigger an AI stock catalyst alert?
$SEPN triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +2.0/10). Headline: Septerna Selects SEP-204 as Candidate for Graves' Disease and TED. Key points: - Selected SEP-204 as development candidate for Graves' Disease and Thyroid Eye Disease (TED) - Favorable preclinical PK profile supporting once-daily oral dosing; Phase 1 trial planned for Q1 2027
How did $SEPN stock react after the SEC filing?
After the SEC 8-K for $SEPN, observed market reaction: T0 price $43.70. Past moves do not guarantee future results.
Where can I get real-time $SEPN SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $SEPN via Telegram and the VIP Web Terminal from €10/month.